US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 0.970
  • -0.002-0.23%
Close Dec 30 16:00 ET
  • 0.968
  • -0.002-0.21%
Post 20:01 ET
44.35MMarket Cap-0.63P/E (TTM)

Xilio Therapeutics Key Stats

Xilio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.900M--
--2024/Q4-- / 3.300M--
--2024/Q32.263M / 3.300M--
--2024/Q22.357M / 30.000M--
--2024/Q10.000 / 10.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.900M--
--2024/Q4-- / 3.300M--
--2024/Q32.263M / 3.300M--
--2024/Q22.357M / 30.000M--
--2024/Q10.000 / 10.000M--

Unlock Free Earnings Estimates

Xilio Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 8, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data